Velocity Clinical Research

Executive Summary

Velocity Clinical Research is the world’s leading integrated clinical trial site organization, operating a unified network of research sites across the U.S. and Europe. Founded in 1986 and headquartered in Durham, North Carolina, the company partners with pharmaceutical and biotechnology firms to deliver high-quality clinical trial data and patient care. By simplifying site operations, ensuring reliable patient enrollment, and providing predictable performance, Velocity plays a critical role in accelerating the development of new therapies. Its scale and integrated model offer sponsors a streamlined, single-point-of-contact solution for multi-site trials, reducing complexity and improving data quality. As the clinical trial landscape becomes increasingly decentralized and patient-centric, Velocity is well-positioned to capture market share through its established infrastructure and reputation for operational excellence. Velocity’s growth strategy centers on expanding its site network (both organically and via acquisitions) and investing in technology to enhance patient recruitment and site efficiency. The company’s private status enables long-term strategic investments without quarterly earnings pressure. With the clinical trial market expanding due to rising R&D spend and an aging population, Velocity stands to benefit from sponsors seeking reliable, high-performance site partners. However, competition from other site networks and the inherent risks of clinical trial execution (enrollment delays, regulatory changes) are ongoing challenges. Overall, Velocity Clinical Research demonstrates a robust business model with strong fundamentals and a clear path to capturing growth in the clinical trial outsourcing market.

Upcoming Catalysts (preview)

• Q4 2026Expansion of European site network through acquisitions75% success
• Q3 2026New multi-year partnership with a top-10 pharmaceutical company60% success
• Q2 2026Launch of a digital patient enrollment platform80% success